{
    "clinical_study": {
        "@rank": "62139", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Eletriptan 40 mg", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Eletriptan 80 mg", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "To determine the tolerability and efficacy of eletriptan in patients who had discontinued\n      oral sumatriptan due to lack of efficacy or intolerable adverse events (AEs) during previous\n      clinical treatment (not a controlled trial)."
        }, 
        "brief_title": "Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan", 
        "completion_date": {
            "#text": "September 2000", 
            "@type": "Actual"
        }, 
        "condition": "Migraine With or Without Aura", 
        "condition_browse": {
            "mesh_term": "Migraine Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female subjects age \u2265 18 years who met the International Headache Society\n             (IHS) diagnostic criteria for migraine, with or without aura, and could reasonably\n             expect to suffer at least one acute attack of migraine every 6 weeks.\n\n          -  Subjects required to have discontinued therapy with oral sumatriptan at least 2\n             weeks, but not longer than 2 years, prior to the screening visit.\n\n          -  Female subjects required to be adequately protected against pregnancy.\n\n        Exclusion Criteria:\n\n          -  pregnancy or breastfeeding, known coronary artery disease, significant arrhythmias,\n             heart failure, significant ECG abnormalities, and uncontrolled hypertension.\n\n          -  Any significant systemic, organ, neurological, endocrine, metabolic, and\n             psychological disorders reported by the patient or discovered during the physical\n             examination\n\n          -  Subjects considered to have atypical migraine such as frequent attacks, prolonged\n             aura or any migraine that was considered atypical.\n\n          -  Subjects who, during the course of the trial, required treatment with sumatriptan or\n             any other 5-HT1B/1D agonist in addition to study medication."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "68 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "446", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01989936", 
            "org_study_id": "A1601006"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo", 
                "description": "Subjects were randomized to one of the 3 treatment groups (eletriptan 40 mg, eletriptan 80 mg, or placebo) in a 2:2:1 ratio and were given sufficient medication to treat 3 migraine attacks (including a second dose for each attack for recurrence) within 18 weeks of the initial visit. Subjects were instructed to treat a moderate to severe migraine within 6 hours of the onset of pain provided the headache was not decreasing in severity, the aura phase had ended and they had taken no analgesic or antiemetic within 6 hours. Efficacy data was collected in a diary. Subjects were allowed to take rescue medication if they had no response to the study medication within 4 hours of onset.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Eletriptan 40 mg", 
                "description": "Subjects were randomized to one of the 3 treatment groups (eletriptan 40 mg, eletriptan 80 mg, or placebo) in a 2:2:1 ratio and were given sufficient medication to treat 3 migraine attacks (including a second dose for each attack for recurrence) within 18 weeks of the initial visit. Subjects were instructed to treat a moderate to severe migraine within 6 hours of the onset of pain provided the headache was not decreasing in severity, the aura phase had ended and they had taken no analgesic or antiemetic within 6 hours. Efficacy data was collected in a diary. Subjects were allowed to take rescue medication if they had no response to the study medication within 4 hours of onset.", 
                "intervention_name": "Eletriptan 40 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Eletriptan 80 mg", 
                "description": "Subjects were randomized to one of the 3 treatment groups (eletriptan 40 mg, eletriptan 80 mg, or placebo) in a 2:2:1 ratio and were given sufficient medication to treat 3 migraine attacks (including a second dose for each attack for recurrence) within 18 weeks of the initial visit. Subjects were instructed to treat a moderate to severe migraine within 6 hours of the onset of pain provided the headache was not decreasing in severity, the aura phase had ended and they had taken no analgesic or antiemetic within 6 hours. Efficacy data was collected in a diary. Subjects were allowed to take rescue medication if they had no response to the study medication within 4 hours of onset.", 
                "intervention_name": "Eletriptan 80 mg", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Sumatriptan", 
                "Eletriptan"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 20, 2013", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1601006&StudyName=Eletriptan%20for%20the%20Treatment%20of%20Migraine%20in%20Patients%20with%20Previous%0APoor%20Response%20or%20Tolerance%20to%20Oral%20Sumatriptan"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Arhus C", 
                        "country": "Denmark", 
                        "zip": "8000"
                    }, 
                    "name": "Arhus Kommunehospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Esbjerg", 
                        "country": "Denmark", 
                        "zip": "6700"
                    }, 
                    "name": "Centralsygehuset I Esbjerg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glostrup", 
                        "country": "Denmark", 
                        "zip": "2600"
                    }, 
                    "name": "Kas Glostrup"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hilleroed", 
                        "country": "Denmark", 
                        "zip": "3400"
                    }, 
                    "name": "Hilleroed Sygehus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hjorring", 
                        "country": "Denmark", 
                        "zip": "9800"
                    }, 
                    "name": "Knud Kjaersgaard Pedersen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f8benhavn", 
                        "country": "Denmark", 
                        "zip": "2400"
                    }, 
                    "name": "Bispebjerg Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nykoebing F", 
                        "country": "Denmark", 
                        "zip": "4800"
                    }, 
                    "name": "Neubauer, Ole (Private Practice)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Odense C", 
                        "country": "Denmark", 
                        "zip": "5000"
                    }, 
                    "name": "Korsgaard, Anne G. (Private Practice)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haukipudas", 
                        "country": "Finland", 
                        "zip": "90830"
                    }, 
                    "name": "Haukiputaan Laakarikeskus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsinki", 
                        "country": "Finland", 
                        "zip": "00290"
                    }, 
                    "name": "Helsinki University Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hyvinkaa", 
                        "country": "Finland", 
                        "zip": "05850"
                    }, 
                    "name": "Hyvinkaa District Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jyvaskyla", 
                        "country": "Finland", 
                        "zip": "40100"
                    }, 
                    "name": "Torikeskuksen Laakariasema"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mikkeli", 
                        "country": "Finland", 
                        "zip": "50100"
                    }, 
                    "name": "Mikkelin Paansarkypoliklinikka (Mikkeli Headache)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pori", 
                        "country": "Finland", 
                        "zip": "28100"
                    }, 
                    "name": "Porin Laakarikeskus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Turku", 
                        "country": "Finland", 
                        "zip": "20110"
                    }, 
                    "name": "Turku Headache Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "'s-hertogenbosch", 
                        "country": "Netherlands", 
                        "zip": "5223GV"
                    }, 
                    "name": "Bosch Medicentrum (Locatie Willem Alexander Ziekenhuis)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1061 AE"
                    }, 
                    "name": "Sint Lucas Andreas Ziekenhuis (Location: St.Lucas)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Netherlands"
                    }, 
                    "name": "Sint Anna Ziekenhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Netherlands"
                    }, 
                    "name": "Nijmeegs Interkonfessioneel Ziekenhuis Canisius-Wilhelmina"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nordbyhagen", 
                        "country": "Norway", 
                        "zip": "1474"
                    }, 
                    "name": "Sentralsykehuset I Akershus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "0303"
                    }, 
                    "name": "Volvat Medisinske Senter"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "0166"
                    }, 
                    "name": "Private Practice, Oyvind Rosjo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tonsberg", 
                        "country": "Norway", 
                        "zip": "3111"
                    }, 
                    "name": "Strandquist, Dr. Stein Bror"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Norway"
                    }, 
                    "name": "Sentralsjukehuset I Hedmark"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Norway"
                    }, 
                    "name": "Fylkessjukehuset I Molde"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Norway"
                    }, 
                    "name": "Regionsykehuset I Trondheim"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Goeteborg", 
                        "country": "Sweden", 
                        "zip": "SE-411 17"
                    }, 
                    "name": "Migranklinik-Goeteborg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsingborg", 
                        "country": "Sweden", 
                        "zip": "251 87"
                    }, 
                    "name": "Neurologsektionen, Lasarettet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsingborg", 
                        "country": "Sweden", 
                        "zip": "25221"
                    }, 
                    "name": "Neuro Kliniken, Helsingborg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kristinehamn", 
                        "country": "Sweden", 
                        "zip": "681 80"
                    }, 
                    "name": "Medicin Kliniken, Sjukhuset"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lund", 
                        "country": "Sweden", 
                        "zip": "22185"
                    }, 
                    "name": "Medicin Kliniken, Universitetssjukhuset"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "SE-112 81"
                    }, 
                    "name": "St Gorans Sjukhus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden", 
                        "zip": "162 68"
                    }, 
                    "name": "Lakarhuset"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden"
                    }, 
                    "name": "Huslakargruppen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden", 
                        "zip": "612 25"
                    }, 
                    "name": "Primarvarden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden"
                    }, 
                    "name": "Danderydssjukhus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden", 
                        "zip": "660 60"
                    }, 
                    "name": "Vardcentralen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden"
                    }, 
                    "name": "Lundsbysjukhus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden", 
                        "zip": "392 31"
                    }, 
                    "name": "Foretagshalsovarden Linden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden", 
                        "zip": "216 16"
                    }, 
                    "name": "Limhamns Lakargrupp, Tarnan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden", 
                        "zip": "971 06"
                    }, 
                    "name": "Lakarhuset Hermelinen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Unknown", 
                        "country": "Sweden", 
                        "zip": "600 02"
                    }, 
                    "name": "Medicinskt Centrum"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vaexjoe", 
                        "country": "Sweden", 
                        "zip": "SE-352 34"
                    }, 
                    "name": "Kronobergskliniken"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Denmark", 
                "Finland", 
                "Netherlands", 
                "Norway", 
                "Sweden"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multicenter, Double - Blind, Randomized, Placebo - Controlled Parallel Group Study of the Efficacy and Safety of Oral Eletriptan (40 and 80mg) Given for the Treatment of Acute Migraine in Subjects Discontinued From Oral Sumatriptan", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Independent Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2000", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Subjects recorded the intensity of each migraine headache in the diary based on a 4-point scale: 0, pain absent; 1, mild pain; 2, moderate pain; 3, severe pain. A response was considered a change from severe or moderate pain to mild or absent at various time points after dosing with study medication", 
            "measure": "The primary efficacy endpoint was 2-h headache response after taking the first dose of study medication for the first attack", 
            "safety_issue": "No", 
            "time_frame": "18 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01989936"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Recurrence was defined as a return of headache to moderate or severe intensity within 2-24 h if the subject had an initial response within 2 h of taking the study medication.", 
            "measure": "Sustained response was defined as achieving a headache response within 2 h post dose, with no recurrence or rescue medication needed", 
            "safety_issue": "No", 
            "time_frame": "18 weeks"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 1999", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}